Literature DB >> 25660467

White matter changes in first episode psychosis and their relation to the size of sample studied: a DTI study.

T Melicher1, J Horacek2, J Hlinka3, F Spaniel2, J Tintera4, I Ibrahim4, P Mikolas2, T Novak2, P Mohr2, C Hoschl2.   

Abstract

BACKGROUND: White matter abnormality has been recently proposed as a pathophysiological feature of schizophrenia (SZ). However, most of the data available has been gathered from chronic patients, and was therefore possibly confounded by factors such as duration of the disease, and treatment received. The extent and localization of these changes is also not clear.
METHODS: We examined a population of early stage SZ patients using diffusion tensor imaging (DTI). 77 SZ patients and 60 healthy controls (HCs) were included in the analysis using Tract-Based Spatial Statistics (TBSS). We have also analyzed 250 randomly created subsets of the original cohort, to investigate the relation between the result of TBSS analysis, and the size of the sample studied.
RESULTS: We have found a significant decrease in fractional anisotropy (FA) in the patient group. This change is present in most major white matter (WM) tracts including the corpus callosum, superior and inferior longitudinal fasciculi, inferior fronto-occipital fasciculus, and posterior thalamic radiation. Furthermore, we identified a clear trend towards an increase in the number and spatial extent of significant voxels reported, with an increasing number of subjects included in the analysis.
CONCLUSION: Our study shows that FA is significantly decreased in patients at an early stage of schizophrenia, and that the extent of this finding is dependent on the size of studied sample; therefore underpowered studies might produce results with false spatial localization.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diffusion tensor imaging; First episode psychosis; Fractional anisotropy; Schizophrenia; Tract-Based Spatial Statistics

Mesh:

Year:  2015        PMID: 25660467     DOI: 10.1016/j.schres.2015.01.029

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  23 in total

1.  Brain Age in Early Stages of Bipolar Disorders or Schizophrenia.

Authors:  Tomas Hajek; Katja Franke; Marian Kolenic; Jana Capkova; Martin Matejka; Lukas Propper; Rudolf Uher; Pavla Stopkova; Tomas Novak; Tomas Paus; Miloslav Kopecek; Filip Spaniel; Martin Alda
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

2.  A combined VBM and DTI study of schizophrenia: bilateral decreased insula volume and cerebral white matter disintegrity corresponding to subinsular white matter projections unlinked to clinical symptomatology.

Authors:  Aslıhan Onay; Hale Yapıcı Eser; Çiğdem Ulaşoğlu Yıldız; Selçuk Aslan; Erhan Turgut Talı
Journal:  Diagn Interv Radiol       Date:  2017 Sep-Oct       Impact factor: 2.630

3.  Negative symptoms are associated with modularity and thalamic connectivity in schizophrenia.

Authors:  Adem Bayrakçı; Nabi Zorlu; Merve Karakılıç; Funda Gülyüksel; Berna Yalınçetin; Elif Oral; Fazıl Gelal; Emre Bora
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-06-03       Impact factor: 5.270

4.  Cognitive deficits, clinical variables, and white matter microstructure in schizophrenia: a multisite harmonization study.

Authors:  Johanna Seitz-Holland; Joanne D Wojcik; Suheyla Cetin-Karayumak; Amanda E Lyall; Ofer Pasternak; Yogesh Rathi; Mark Vangel; Godfrey Pearlson; Carol Tamminga; John A Sweeney; Brett A Clementz; David A Schretlen; Petra Verena Viher; Katharina Stegmayer; Sebastian Walther; Jungsun Lee; Tim Crow; Anthony James; Aristotle Voineskos; Robert W Buchanan; Philip R Szeszko; Anil K Malhotra; Sinead Kelly; Martha E Shenton; Matcheri S Keshavan; Raquelle I Mesholam-Gately; Marek Kubicki
Journal:  Mol Psychiatry       Date:  2022-08-18       Impact factor: 13.437

5.  Differential Time Course of Microstructural White Matter in Patients With Psychotic Disorder and Individuals at Risk: A 3-Year Follow-up Study.

Authors:  Patrick Domen; Sanne Peeters; Stijn Michielse; Ed Gronenschild; Wolfgang Viechtbauer; Alard Roebroeck; Jim van Os; Machteld Marcelis
Journal:  Schizophr Bull       Date:  2016-05-17       Impact factor: 9.306

6.  Persistent Microstructural Deficits of Internal Capsule in One-Year Abstinent Male Methamphetamine Users: a Longitudinal Diffusion Tensor Imaging Study.

Authors:  Wenxu Zhuang; Yingying Tang; Na Zhong; Haifeng Jiang; Jiang Du; Jijun Wang; Min Zhao
Journal:  J Neuroimmune Pharmacol       Date:  2016-04-26       Impact factor: 4.147

Review 7.  Annual Research Review: Enduring neurobiological effects of childhood abuse and neglect.

Authors:  Martin H Teicher; Jacqueline A Samson
Journal:  J Child Psychol Psychiatry       Date:  2016-02-01       Impact factor: 8.982

8.  Elucidating the relationship between white matter structure, demographic, and clinical variables in schizophrenia-a multicenter harmonized diffusion tensor imaging study.

Authors:  Johanna Seitz-Holland; Suheyla Cetin-Karayumak; Matcheri Keshavan; Marek Kubicki; Joanne D Wojcik; Amanda Lyall; James Levitt; Martha E Shenton; Ofer Pasternak; Carl-Fredrik Westin; Madhura Baxi; Sinead Kelly; Raquelle Mesholam-Gately; Mark Vangel; Godfrey Pearlson; Carol A Tamminga; John A Sweeney; Brett A Clementz; David Schretlen; Petra Verena Viher; Katharina Stegmayer; Sebastian Walther; Jungsun Lee; Tim Crow; Anthony James; Aristotle Voineskos; Robert W Buchanan; Philip R Szeszko; Anil K Malhotra; Yogesh Rathi
Journal:  Mol Psychiatry       Date:  2021-01-22       Impact factor: 13.437

Review 9.  Alterations of the occipital lobe in schizophrenia.

Authors:  Hassaan Tohid; Muhammad Faizan; Uzma Faizan
Journal:  Neurosciences (Riyadh)       Date:  2015-07       Impact factor: 0.906

10.  A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human Studies.

Authors:  Eva A Malt; Katalin Juhasz; Ulrik F Malt; Thomas Naumann
Journal:  Front Behav Neurosci       Date:  2016-03-30       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.